AS Latvijas Juras medicinas centrs Stock Nasdaq Riga

Equities

LJM1R

LV0000100741

Healthcare Facilities & Services

Market Closed - Nasdaq Riga 07:44:49 2024-04-18 am EDT 5-day change 1st Jan Change
7 EUR -7.89% Intraday chart for AS Latvijas Juras medicinas centrs -22.22% -29.65%
Sales 2020 7.08M 7.53M Sales 2021 9.36M 9.96M Capitalization 10.16M 10.81M
Net income 2020 - 0 Net income 2021 - 0 EV / Sales 2020 0.59 x
Net cash position 2020 1.77M 1.88M Net cash position 2021 1.02M 1.08M EV / Sales 2021 0.98 x
P/E ratio 2020
21.8 x
P/E ratio 2021
11.5 x
Employees 361
Yield 2020
0.94%
Yield 2021
1.57%
Free-Float 26.16%
More Fundamentals * Assessed data
Dynamic Chart
AS Latvijas Juras medicinas centrs Reports Earnings Results for the Full Year Ended December 31, 2023 CI
AS Latvijas Juras medicinas centrs Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
AS Latvijas Juras medicinas centrs Reports Earnings Results for the Half Year Ended June 30, 2023 CI
AS Latvijas Juras Medicinas Centrs Announces Dividend Payment, Payable December 1, 2023 CI
AS Latvijas Juras medicinas centrs Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
AS Latvijas Juras medicinas centrs Reports Earnings Results for the Full Year Ended December 31, 2022 CI
AS Latvijas Juras medicinas centrs Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
AS Latvijas Juras medicinas centrs Reports Earnings Results for the Half Year Ended June 30, 2022 CI
AS Latvijas Juras medicinas centrs to Pay Dividend, Payable on June 28, 2022 CI
AS Latvijas Juras medicinas centrs Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
AS Latvijas Juras medicinas centrs Reports Earnings Results for the Full Year Ended December 31, 2021 CI
AS Latvijas Juras medicinas centrs Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
As Latvijas Juras Medicinas Centrs Reports Earnings Results for the Half Year Ended June 30, 2021 CI
A/S Latvijas Juras Medicinas Centrs Declares Dividend, Payable on June 30, 2021 CI
A/S Latvijas Juras Medicinas Centrs Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
More news
1 day-7.89%
1 week-22.22%
Current month-30.00%
1 month-14.11%
3 months-30.69%
6 months-30.00%
Current year-29.65%
More quotes
1 week
7.00
Extreme 7
9.00
1 month
7.00
Extreme 7
10.00
Current year
5.70
Extreme 5.7
10.10
1 year
5.70
Extreme 5.7
11.00
3 years
5.70
Extreme 5.7
19.90
5 years
4.00
Extreme 4
19.90
10 years
2.00
Extreme 2
19.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 96-08-26
Director of Finance/CFO 53 12-08-31
Comptroller/Controller/Auditor - -
Members of the board TitleAgeSince
Director/Board Member 76 10-04-27
Chairman 41 06-12-17
Director/Board Member 73 08-04-29
More insiders
Date Price Change Volume
24-04-18 7 -7.89% 398
24-04-15 7.6 +0.66% 57
24-04-12 7.55 -16.11% 3
24-04-11 9 +20.00% 12

Delayed Quote Nasdaq Riga, April 18, 2024 at 07:44 am EDT

More quotes
Latvijas Juras Medicinas Centrs AS (Latvian Maritime Medicine Center JSC or LJMC JSC) is a Latvia-based company engaged in the provision of healthcare services. LJMC operates Central Hospital, Vecmilgravis Hospital and Northern Diagnostic Center, as well as Vecmilgravis Primary Health Care Center (Vecmilgravis PHCC) and Sarkandaugava ambulatory health care center. It provides diagnostics services, such as cardiovascular, surgical, radiological, gastrointestinal disease diagnostics and magnetic resonance. The Company operates two subsidiaries, Juras medicina Ltd and Neirozu klinika SIA. It is active domestically and offers its services on the whole territory of Latvia. In addition, it cooperates with health insurance companies.
More about the company